Jay K. Trautman

GenEncap, Inc. develops and commercializes DNA sequencing technology. It offers proprietary technologies and massively-parallel sanger sequencing. The company was founded by Kevin M. Ulmer on June 19, 2007 and is headquartered in Providence, RI.

Invenio Imaging, Inc. provides treatment for cancer through label-free chemical imaging and fiber-laser technology. Its NIO Imaging System is designed to streamline intraoperative histology, reducing downtime in the OR and allowing examination of specimens from multiple sites in the surgical cavity. The company was founded in 2012 and is headquartered in Santa Clara, CA.

Photoswitch Therapeutics, Inc. operates as biotechnology company. The company was founded in 2017 and is headquartered in Menlo Park, CA.

Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation.

Part of GE Healthcare Technologies, Inc., Praelux, Inc. is a company that develops secondary drug screening technologies. The company is based in Lawrenceville, NJ. The company was founded by Bob F. Johnston. Praelux was acquired by Amersham Pharmacia Biotech, Inc. on February 16, 2000.

Photoswitch Biosciences, Inc. creates advanced tools to drive next-generation membrane biology discoveries. Its products include bolt and PhoS VSD. The company was founded by Jay Trautman, Andy Blatz, Jonathan Ross, Ehud Isacoff, Richard Kramer and Dirk Trauner and is headquartered in Cleveland, OH.